abstract |
Porphyrin prevention and treatment of cardiac arrhythmias The present invention is directed to the use of porphyrin mnt-2-pyp5 + for the prevention and treatment of cardiac arrhythmias for its application in both human and veterinary medicine. The effects on reducing the arrhythmia score, on the severity and duration of arrhythmic events stand out, preventing or restoring healthy conditions in the individual. |